Cyclopharm Management
Management criteria checks 1/4
Cyclopharm's CEO ist James McBrayer , ernannt in Jun 2008, hat eine Amtszeit von 15.67 Jahren. Die jährliche Gesamtvergütung beträgt A$849.59K , bestehend aus 51.7% Gehalt und 48.3% Boni, einschließlich Aktien und Optionen des Unternehmens. besitzt direkt 5.64% der Aktien des Unternehmens, im Wert von A$9.72M . Die durchschnittliche Betriebszugehörigkeit des Managementteams und des Verwaltungsrats beträgt 4.4 Jahre bzw. 2.5 Jahre.
Key information
James McBrayer
Chief executive officer
AU$893.5k
Total compensation
CEO salary percentage | 52.7% |
CEO tenure | 15.8yrs |
CEO ownership | 5.6% |
Management average tenure | 5.9yrs |
Board average tenure | 2.1yrs |
Recent management updates
Recent updates
What You Can Learn From Cyclopharm Limited's (ASX:CYC) P/SAfter Its 26% Share Price Crash
Oct 28Is Cyclopharm Limited (ASX:CYC) Trading At A 25% Discount?
Apr 18Companies Like Cyclopharm (ASX:CYC) Are In A Position To Invest In Growth
Mar 31Companies Like Cyclopharm (ASX:CYC) Can Afford To Invest In Growth
Oct 17Companies Like Cyclopharm (ASX:CYC) Can Afford To Invest In Growth
Jun 09Analyst Forecasts For Cyclopharm Limited (ASX:CYC) Are Surging Higher
Mar 06Here's Why We're Not At All Concerned With Cyclopharm's (ASX:CYC) Cash Burn Situation
Mar 02We Think Cyclopharm (ASX:CYC) Can Afford To Drive Business Growth
Oct 22Cyclopharm Limited's (ASX:CYC) Analyst Just Slashed This Year's Estimates
Jun 29Shareholders Will Probably Hold Off On Increasing Cyclopharm Limited's (ASX:CYC) CEO Compensation For The Time Being
Apr 27Rainbows and Unicorns: The Cyclopharm Limited (ASX:CYC) Analyst Just Became A Lot More Optimistic
Mar 01Cyclopharm (ASX:CYC) Has Rewarded Shareholders With An Exceptional 401% Total Return On Their Investment
Feb 07Is Cyclopharm Limited (ASX:CYC) Popular Amongst Insiders?
Jan 02We're Not Very Worried About Cyclopharm's (ASX:CYC) Cash Burn Rate
Dec 06CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Dec 31 2023 | AU$893k | AU$471k | -AU$5m |
Sep 30 2023 | n/a | n/a | -AU$6m |
Jun 30 2023 | n/a | n/a | -AU$7m |
Mar 31 2023 | n/a | n/a | -AU$7m |
Dec 31 2022 | AU$850k | AU$439k | -AU$7m |
Sep 30 2022 | n/a | n/a | -AU$5m |
Jun 30 2022 | n/a | n/a | -AU$4m |
Mar 31 2022 | n/a | n/a | -AU$4m |
Dec 31 2021 | AU$957k | AU$427k | -AU$5m |
Sep 30 2021 | n/a | n/a | -AU$5m |
Jun 30 2021 | n/a | n/a | -AU$4m |
Mar 31 2021 | n/a | n/a | -AU$5m |
Dec 31 2020 | AU$1m | AU$406k | -AU$6m |
Sep 30 2020 | n/a | n/a | -AU$6m |
Jun 30 2020 | n/a | n/a | -AU$6m |
Mar 31 2020 | n/a | n/a | -AU$4m |
Dec 31 2019 | AU$753k | AU$341k | -AU$3m |
Sep 30 2019 | n/a | n/a | -AU$3m |
Jun 30 2019 | n/a | n/a | -AU$2m |
Mar 31 2019 | n/a | n/a | -AU$1m |
Dec 31 2018 | AU$426k | AU$335k | -AU$35k |
Sep 30 2018 | n/a | n/a | -AU$409k |
Jun 30 2018 | n/a | n/a | -AU$782k |
Mar 31 2018 | n/a | n/a | -AU$1m |
Dec 31 2017 | AU$421k | AU$327k | -AU$2m |
Vergütung im Vergleich zum Markt: JamesDie Gesamtvergütung ($USD556.34K) liegt über dem Durchschnitt von Unternehmen ähnlicher Größe auf dem Markt Australian ($USD292.11K).
Entschädigung vs. Einkommen: JamesDie Bezüge der Mitarbeiter sind gestiegen, während das Unternehmen unrentabel ist.
CEO
James McBrayer (58 yo)
15.8yrs
Tenure
AU$893,462
Compensation
Mr. James S. McBrayer, BSPharm, GDM, FAICD, AIM, has been the Managing Director at Cyclopharm Ltd. since June 3, 2008 and also serves as its Chief Executive Officer. Mr. McBrayer has been Company Secretary...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
CEO, MD | 15.8yrs | AU$893.46k | 5.64% A$ 9.4m | |
Chief Operating Officer | 7.3yrs | AU$484.33k | 0.53% A$ 885.0k | |
Finance Manager | no data | AU$152.73k | no data | |
Head of Sales | 4.6yrs | no data | no data | |
Head of Quality and Regulatory | 4.6yrs | no data | no data | |
Head of Service | 4.6yrs | no data | no data | |
Financial Controller | 13.1yrs | AU$64.44k | no data | |
General Manager of Canada | no data | AU$173.42k | no data | |
Quality & Regulatory Manager | no data | AU$151.96k | no data |
5.9yrs
Average Tenure
Erfahrenes Management: Das Managementteam von CYC ist erfahren und erfahren (durchschnittliche Amtszeit: 5.9 Jahre).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
CEO, MD | 15.8yrs | AU$893.46k | 5.64% A$ 9.4m | |
Independent Non-Executive Director | 2.7yrs | AU$60.76k | 0.011% A$ 17.7k | |
Independent Non-Executive Chairman | 17.4yrs | AU$85.07k | 0.30% A$ 495.6k | |
Non-Executive Director | less than a year | no data | no data | |
Independent Non-Executive Director | 1.6yrs | AU$60.76k | 0.012% A$ 19.5k | |
Independent Non-Executive Director | 1.6yrs | AU$60.76k | no data |
2.1yrs
Average Tenure
63yo
Average Age
Erfahrener Vorstand: CYCDie Vorstandsmitglieder gelten nicht als erfahren ( 2.5 Jahre durchschnittliche Amtszeit), was auf einen neuen Vorstand hindeutet.